The upregulation of TRPV4/Piezo1 transcription by TGFβ2 predicts exaggerated responsiveness to mechanical loading, as reported for chemotherapy (108), neuropathic pain (109, 110), cancer (111), and diabetic neuropathy (112). The gene discussed is TGFB2; the disease is diabetic neuropathy.